Get Permission Mehmood, Anwar ul-Haq, Tariq, Fayyaz, Ameen, and Sharif: PCR-based detection and mutation dynamics of fusion protein gene of orthoaviula viruses sequestered during 2023 field outbreaks in Pakistan


Introduction

Newcastle disease is a communicable and potentially terminal illness in avian species world wide. It effects respiratory, digestive and nervous system even simultaneously and is characterized by circulatory and respiratory distress, rattling, sneezing, watery eyes, diarrhea and damaged to central nervous system depending upon the tissue tropism of viral strains. Certain factors like the bird's age, dose, route of administration and environmental conditions affect the severity of infection. In young birds, NDV produces a fatal disease with no apparent clinical signs or symptoms while in older birds it remained carrier for longer period of time as subclinical infection.1

The causative agent of Newcastle disease is the Newcastle disease virus that belongs to Avian Paramyxovirus Serotype 1 from the genus Orthoavulavirus, family Paramyxoviridae, and sub-family Paramyxovirinae.2 It is an enveloped, negative sense, single-stranded RNA virus with a genome length of 15,186 nucleotides.3 The virus genome encodes six proteins including hemagglutinin-neuraminidase (HN), fusion (F), nucleocapsid (NP), phosphoprotein (P), matrix (M), and the RNA-dependent RNA polymerase (L).4 The two major membrane proteins, Hemagglutinin-Neuraminidase (HN) and fusion protein are involved in virus attachment and the release and fusion of viral envelop with the host cell membrane respectively. The fusion protein is formed as a precursor Fo, its gets bifurcate into F1 and F2 which is mandatory to initiate the viral infection by NDV.5

The host's susceptibility to the NDV virulent strains is determined by factors like organ or tissue tropism and the host's immune status.6 Two major systems have been adopted worldwide to catagarize NDV strains associates with Avian Paramyxovirus Serotype 1. The first system proposed by Aldous and fellows classifies the NDV strains into 6 lineages (1-6) and 13 sublineages.7 The Latter system divides the NDV into two categories; Class I and Class II. Here, class I consists of 1 genotype and 3 sub-genotypes (1.1.1, 1.1.2, 1.2) and class II contains 15 genotypes (I-XV). The genotype I is further divided into sub-genotypes Ia and Ib, genotype II into II and IIa, Genotype VI into VIa-VIf, and Genotype VII into VIIa-VIIh.8 Among these two classes, Class I comprises only avirulent strains, and contrarily, both avirulent and virulent strains are included in Class II. The Globally used avirulent Vaccinal Strains LaSota and B1 are also classified as the Genotype II strains in Class II.9

The third system classifies NDV strains into three pathotypes; Lentogenic, mesogenic, and velogenic. The first two pathotypes are associates with no or low-risk infection and the third pathotype is responsible for the deadly NDV infections. Furthermore, the Velogenic strains causes diarrhea hemrragic intestinal lesions, respiratory and nervousness.10

The studies have shown that strain to strain difference even having identical fusion protein cleavage site sequences. So, it adds to the idea that despite fusion protein bring the major virulence factor, other proteins on the NDV surface also contribute to its pathogenicity. One of the major proteins is HN which is involved in the fusion process and ultimately aids in initiating this viral infection. The V protein is an interferon antagonist that is involved in the host range restriction and pathogenicity of Newcastle disease virus.11

The conventional methods for the detection of NDV in clinical cases include virus cultivation in embryonated eggs/ tissue cultue, intracerebral pathogenicity index (ICPI), the intravenous pathogenicity index (IVPI) or the mean death time (MDT) have been overtook by the molecular biology tools due to their laborious and time-consuming nature. Nowadays, the allied detection methods including Virus cultivation, Hemagglutination Inhibition (HI), and rt-PCR followed by sequencing and mutation analysis of the nucleotide and amino acid sequence are considered to be reliable methods for the accurate detection and confirmation of NDV.

In light of the above-mentioned observations, the current study has been undertaken to investigate the molecular characteristics of the partial fusion protein gene of indigenous isolates recovered from the commercial flocks reported with high mortality in the field. The study aims to derive the role of fusion protein gene sequence mutation on protein translations that were responsible for the disastrous conditions in commercial poultry in NDV-immunized flocks.

Aims and Objectives

  1. Isolation and detection of Newcastle disease virus in commercial poultry.

  2. Molecular characterization and phylogenetic analysis of the confirmed isolates.

  3. Multiple sequence allingment and achievement of accession numbers against our submissions in NCBI bankit.

Materials and Methods

Study design

In the present study, we demonstrate NDV strain-to-strain variation of field isolates based on partial fusion protein gene analysis and various mutation sites in association with database-validated information using the NCBI portal.

Duration of study

One year (January 2023- January 2024).

Sample Collection and Processing

During 2023-2024, a total of Eighty samples were collected from vaccinated broiler flocks from Lahore, Karachi, Islamabad, Rawalpindi, and other areas of Punjab, Pakistan as predicted in Table 1 . These flocks manifested the clinical signs of Newcastle disease including circulatory and respiratory disturbance (watery eyes, rales, sneezing), nervous signs (tremor, wryneck, opisthotonus), digestive signs (watery greenish diarrhea), and drop in egg production. Upon postmortem, petechial hemorrhages were observed in the serosa of the intestine and proventriculus gland along with the hemorrhagic necrosis at multiple foci on the intestinal mucosa, cecal tonsils, and Peyer’s patches indicating a viscerotropic Velogenic infection.

Hence, tissue samples including lungs, trachea, spleen, duodenum, and cecal tonsils were collected from each bird and pooled separately for each flock. These samples were processed by grinding one part of the sample into 5 parts of normal saline containing gentamycin (250 mg/ml). The mixture was centrifuged using a Centrifuge machine (SORVALL LEGEND MICRO 17-Thermo SCIENTIFIC-US) at 2000 rpm for 10 minutes at 4oC. The supernatant was collected and stored at -80°C until further use in the virus characterization pending further processing.1

Virus isolation

For the execution of virus isolation, 9-day-old specific pathogen-free eggs were subjected to the inoculation of supernatant (0.1ml/egg) separated earlier via the allantoic sac route. Following incubation of inoculated eggs at 37oC for 36 hours while ensuring the embryo viability by candling the eggs every two hours, eggs were shifted to the freezer at 4oC for 2 hours. After chilling, the amniotic allantoic fluid was harvested and put through a Hemagglutination assay (HA) using 1% chicken RBCs for the confirmation of the egg infection with the suspected virus. Moreover, the preliminary confirmation of isolate as NDV was attained by Hemagglutination Inhibition (HI) Assay employing NDV hyperimmune antisera (GD Laboratories Holland-Lot no: 23129-110523).1

Virus characterization

Favorgen extraction kit was used for the extraction of viral RNA from harvested allantoic fluid of NDV-positive samples. For Polymerase chain reaction (PCR), the transgene kit synthesized the first-strand complementary deoxyribonucleic acid (cDNA). 7ul nuclease-free water, 5ul RNA template, and 1ul each forward and reverse prime were dispensed in 0.5ml Eppendorf tubes. The tubes were incubated at 65oC for 5 minutes, after incubation the tubes were chilled on an ice pack for 2 minutes. After that 1ul reverse transcriptase, 4ul reverse transcriptase buffer, and 1ul dNTPs were added according to the manufacturer's instructions. The following cDNA reaction was compiled 20ul amplified at 42oC for 30 minutes and inactivated at 85oC for 5 minutes. 202bp-sized partial fusion gene of NDV primer Forward: 5'GGTGAGTCTATCCGGARGATACAAG3' and Reverse: 3'TCATTGGTTGCRGCAATGCTCT5' were used. The final total volume of 25ul in which 12ul master mix, 7ul nuclease-free water, 1 ul each forward and reverse prime, and 4ul template were added. The DNA was amplified with an initial denaturation at 95oC for 5 minutes, denaturation at 95oC for 30 sec, annealing at 53oC for 30 sec, and extension at 72oC for 30 sec followed by 30 cycles. The final extension was performed at 72oC for 10 minutes in a Veritii thermocycler (Applied Biosystems-Thermo Fisher-USA) followed by Gel Electrophoresis (Major Science-Taiwan) and band visualization via UV Transilluminator (Vilber Lourmat-France) as can be reviewed in.

Phylogenetic analysis

The PCR amplicon was sent to APICAL SCIENTIFIC SDN. BHD., Malaysia for sequencing. Each sequence was subjected to a Basic Local Alignment Search Tool (BLAST) search to compare it with similar sequences submitted to the National Center for Biotechnology Information (NCBI). Moreover, the phylogenetic comparison was conducted by constructing a maximum likelihood phylogenetic tree in DNASTAR Lasergene Sequence Analysis Software using the MUSCLE alignment algorithm.

Nucleotide sequences accession numbers

The sequences of the isolated NDV strains were submitted to the NCBI GeneBank and are now online.

Results

The prefatory testing via HI and the final characterization by PCR and sequencing gave the out-turn that 14 out of the 80 indigenous isolates were positive for NDV during 2023. We used the NDV-specific primers for PCR that targeted the partial sequence of Newcastle disease virus Fusion protein and generated a 202bp-sized PCR product as shown in Figure 1. Later, the amplified product of each isolate was subjected to sequencing via an automatic sequencer, and raw sequences were examined with BLAST to compare it with the NCBI database for genus and strain level identification. The BLAST comparison predicted that five out of fourteen isolates including OP13, OP14, OP15, OP17, and OP22 belonged to genotype II, and one isolate OP21 belonged to genotype III. The remaining eight isolates OP11, OP12, OP16, OP18, OP19, OP20, OP23, OP24, and OP25 belonged to genotype VII as depicted in Table 1.

Moreover, partial Fusion gene-based phylogenetic analysis of these indigenous isolates led to the conclusion that among five isolates belonging to genotype II, OP13 (OQ622086) showed 100% similarity to the already submitted sequence in NCBI under accession numbers accession number MH407220. Whereas, three isolates OP14 (OQ622087), OP15 (OQ789656), and OP17 (OR269159), showed 100% similarity with the Gene Bank accession number MZ773406 and OP22 (PP316616) showed 98.08% similarity with the accession numbers MZ041713 as exemplified in Table 1.

Likewise, genotype III isolate OP21 (PP228199) showed 98.08% similarity to GeneBank accession number MH392214. On the other hand, among eight genotype VII isolates, OP12 (OQ363107), OP16 (OR269160), OP18 (OR853727), OP19 (OR982193), OP20 (PP196615) showed 97.77%, 95%, 99.32%, 99.32%, 100%, similarity to the accession numbers OK338515, MK903023, MN481193, OK338510, and OR514717 respectively. Besides, the three remaining isolates OP23 (PP359476), OP24 (PP359477), and OP25 (PP388965) depicted 100%, 99.32%, and 91.33% similarity to the accession number OR982193 as can be referred to the Table 1.

In addition, amongst five genotype II isolates OP13 resembles the strain AAvV1-NVMoh19/Iraq/2016, OP14 and OP15 to strain Ae016, and OP17 and OP22 to the vaccinal strain LaSota. Whilst, Genotype III isolate OP21 showed congruence to strain I2. Besides, among eight Genotype VII isolates, OP12 and OP16 were identical to strain abc2, OP18 to chicken/Iran/CI3/2017, while OP19, OP20, OP23, OP24, and OP25 showed similarity to the Avian Paramyxovirus Serotype 1 strain Ck/IR/EMA128/2018 (Table 1).

Figure 1

Gel electrophoresis analysis of NDV. Lane 1 is a 1000bp ladder. Lanes 2-6 and 8-16 are 202bp products of isolates while Lane 5 is negative control

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/e97dbcbd-4b5d-4305-b6a0-eb0eaebb03e5/image/1f925b83-9e2d-4342-a2b7-222b3580b467-uimage.png

Table 1

Details of indigenous NDV isolates (OP12-OP25) in Punjab, Pakistan recovered during 2023-2024 including Sample ID, sample collection date and location, genotype, and accession number of isolate and similar sequence assigned by NCBI

S. No.

Title

Date

Location

Age/Weight (gm)

Reported Mortality (%)

NCBI % Similarity

NCBI

Blast A#

Genotype

NCBI OP A#

Strain

1.

NDV-CK-Danish-AP/Pak-OP12-23

06-01-23

Islamabad

13/ 450

9%

98%

OK338515

Genotype VII

OQ363107

abc2

2.

NDV-CK-Danish-IZC/Pak-OP13-23

17-02-23

Lahore

16/650

10%

100%

MH407220

Genotype II

OQ622086

AAvV1-NVMoh19/ Iraq/2016

3.

NDV-CK-Danish-SP/Pak-OP14-23

20-02-23

Sheikhupura

20/1000

14%

100%

MN599095

Genotype II

OQ622087

Ae016

4.

NDV-CK-Danish-MDV/Pak-OP15-23

14-3-23

Lahore

25/1470

20%

99%

MN599095

Genotype II

OQ789656

Ae016

5.

NDV-CK-Danish-CAN/Pak-OP16-23

29-6-23

Raiwind

9/ 370

8%

96%

MK903023

Genotype VII

OR269160

abc2

6.

NDV-CK-Danish-VP/Pak-OP17-23

18-04-23

Nowshera Virkan

12/400

7%

100%

MN599095

Genotype II

OR269159

LaSota

7.

NDV-CK-Danish-DSD/Pak-OP18-23

16-10-23

Depalpur

17/560

13%

99%

MN481193

Genotype VII

OR853727

chicken/Iran/ CI3/2017

8.

NDV-CK-Danish-AF/Pak-OP19-23

02-11-23

Multan

23/ 950

15%

99%

OK338510

Genotype VII

OR982193

Ck/IR/EMA128/ 2018

9.

NDV-CK-Danish-DWM/Pak-OP20-23

20-11-23

Gujranwala

26/1350

25%

100%

OR514717

Genotype VII

PP196615

Ck/IR/EMA128/ 2018

10.

NDV-CK-Danish-VRI/Pak-OP21-23

20-12-23

Lahore

29/1215

29%

98%

MH392214

Genotype III

PP228199

I2

11.

NDV-CK-Danish-MER/Pak-OP22-23

20-12-23

Lahore

20/ 846

19%

98%

MZ041713

Genotype II

PP316616

LaSota

12.

NDV-CK-Danish-CHP/Pak-OP23-24

21-12-23

Sharaqpur

24/ 980

17%

99%

OR982193

Genotype VII

PP359476

Ck/IR/EMA128/ 2018

13.

NDV-CK-Danish-ZF/Pak-OP24-24

24-12-23

Rawalpindi

27/1352

24%

100 %

OR982193

Genotype VII

PP359477

Ck/IR/EMA128/ 2018

14.

NDV-CK-Danish-EEK/Pak-OP25-24

08-01-24

Karachi

7/410

9%

91%

OR982193

Genotype VII

PP388965

Ck/IR/EMA128/ 2018

[i] Note: The sequencing of PCR amplicon followed by its analysis through BLAST in NCBI contributed to the identification of the partial sequences of the isolates and their division into their respective genotypes. Among the 14 indigenous NDV isolates, OP13, OP14, OP15, OP17, and OP22 were similar to strains in Genotype II, while OP21 showed a close resemblance to Genotype III. Similarly, OP12, OP16, OP18, OP19, OP20, OP23, OP24, and OP25 were identical to strains in Genotype VII.

Figure 2

Phylogenetic analysis of the Partial F-gene sequence Isolated from NDV Strains

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/e97dbcbd-4b5d-4305-b6a0-eb0eaebb03e5/image/d57c4c85-beac-435f-bf85-01eb219e691b-uimage.png

Figure 3

The evolutionary homology and divergence of nucleotide and amino acid sequence between 11 study isolates

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/e97dbcbd-4b5d-4305-b6a0-eb0eaebb03e5/image/68735058-e465-44c5-8aa4-4a5f9db3a0ea-uimage.png

Figure 4

Mutation analysis of nucleotide sequence of Partial Fusion protein gene of NDV isolates (OP12-OP17)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/e97dbcbd-4b5d-4305-b6a0-eb0eaebb03e5/image/c7fc6e8c-63b4-48c0-83ca-7407f4852eec-uimage.png

Figure 5

Mutation analysis of nucleotide sequence of Partial Fusion protein gene of NDV isolates (OP18-OP21)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/e97dbcbd-4b5d-4305-b6a0-eb0eaebb03e5/image/e15b5115-1e00-4560-b31a-2f54d540fa52-uimage.png

Figure 6

Mutation analysis of nucleotide sequence of Partial Fusion protein gene of NDV isolates (OP22-OP25)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/e97dbcbd-4b5d-4305-b6a0-eb0eaebb03e5/image/e824c3f1-2367-440e-aa16-e2c4bc4605ce-uimage.png

Note: The BLAST search of the study indigenous isolates reflected different mutation rates in comparison with closely related sequences submitted in NCBI. NCBI percentage Identity analysis of OP15 with MN599095 as shown in Figure 4, OP18 with MN481193, and OP19 with OK339510 (Figure 5) revealed minimum nucleotide substitution rates at positions (172), (60), and (157) respectively with each having a percentage identity of 99% with subject sequence. Whereas, OP23 and OP22 showed base deletion at positions (126) and (31, 43, 64) in comparison with OR982193 and MZ041713 which had 99% and 98% identity with the query sequence respectively. Besides, analysis of OP21 with MH392214 (98%) suggested nucleotide substitution at positions (82, 157) and deletion at position (41) as can be reviewed in Figure 6.

Moreover, the comparison of OP12 with OK338515 (98% identity) and OP16 with MK903023 (96% identity) showed nucleotide substitution at positions (134, 168, 172, 174) and (24, 36, 44, 77, 78) respectively as illustrated in Figure 4. On the contrary, the identity analysis of OP25 as shown inFigure 6 with OR982193 (91%) showed a maximum mutation rate with nucleotide substitution at positions (40, 45, 46, 50, 69, 89, 90, 91, 112) and nucleotide deletion at positions (52, 65, 155, 162). However, no mutation was recorded during NCBI identity analysis of OP13 with MH407220, OP14 with MN599095, OP17 with MN599095 as can be reviewed in Figure 4, and OP20 with OR514717 (Figure 5), and OP24 with OR982193 (Figure 6) that turned out to be 100% identical.

Figure 7

Mutation in amino acid sequence of Partial Fusion protein gene of NDV isolates (OP12-OP19

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/e97dbcbd-4b5d-4305-b6a0-eb0eaebb03e5/image/61f0b375-eacf-4d3d-ba83-68538cba563a-uimage.png

Figure 8

Mutation in amino acid sequence of Partial Fusion protein gene of NDV isolates (OP20-OP25)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/e97dbcbd-4b5d-4305-b6a0-eb0eaebb03e5/image/1c96463b-91e4-4702-8ff9-72b73f1b4b2b-uimage.png

Note: The comparison of inter amino acid changes in the fusion protein of study NDV isolates and a vaccinal strain led to the outcome that there are various point mutations in the amino acid sequence of the F protein of isolates under study. However, the mutation rate differs in the case of each isolate. The outcomes of the analysis suggested the least substitutions were in OP13, OP14, OP15, OP17 (illustrated in Fig. 7), OP21, and OP22 as portrayed in Figure 8), where amino acid substitutions (R→S, A→S, K→N), (R→K, A→S, K→N), (R→K, A→S, K→N), (R→K, A→S, K→N), (R→G, A→T), and (R→K, A→S, K→N) were observed at positions (12, 38, 44), (13, 39, 45), (15, 41, 47), (13, 39, 45), (3, 47), and (1, 27, 33) respectively.

On the other hand, OP18 and OP19 (as exemplified in Figure 7), OP20, OP23, OP24, and OP25 (as depicted in Figure 8) showed the intermediate number of amino acid substitutions (V→I, I→V, A→S, Q→R, A→T), (V→I, I→V, A→S, Q→R, A→T), (K→G, V→I, A→S, Q→R, A→T), (V→I, I→V, A→S, Q→R, A→T), (V→I, I→V, A→S, Q→R, A→T), and (V→I, I→V, A→S, Q→R, A→T) at positions (7, 11, 25, 39, 45), (7, 11, 25, 39, 45), (3, 9, 27, 41, 47), (6, 10, 24, 38, 44), (6, 10, 24, 38, 44), and (6, 10, 24, 38, 44) respectively.

Contrarily, amino acid substitution analysis in fusion protein depicted maximum mutations in OP12 and OP16 as can be visualized in Figure 8) where amino acid residues (G→E, S→T, R→G, R→G, K→Q, K→G, V→I, I→V, A→S, Q→R) and (G→E, S→T, R→G, R→G, K→Q, K→G, V→I, I→V) mutations were revealed at positions (11, 14, 19, 20, 21, 22, 28, 32, 46, 60) and (11, 14, 19, 20, 21, 22, 28, 32) respectively.

Discussion

Newcastle disease virus is one of the leading concerns in poultry due to its huge economic impact on this sector. So, various strategies including mass immunization have been implemented to bring this virus under control.12 However, it is persisting worldwide though it has changed its course from an endemic to a sporadic disease occurring in the form of outbreaks. The key explanation for this persistence can be attributed to the prevalence of immunosuppressive diseases like AIV, IBD, and/or Marek’s disease in a flock leading to the failure of the vaccine program.13 Another reason could be the divergence within Avian Paramyxovirus Serotype 1 which is the potential hindrance to bringing this disease under control.14 The main objective of this study was to determine the root cause of destructive conditions in the poultry sheds in Punjab, Pakistan where birds were showcasing the signs of this deadly infection.

The decisive factor for pathogenicity concerning the cleavage site of fusion protein is its sequence. The monobasic cleavage site with sequence 112(G/E)(K/R)Q(G/E)RL117 is present in lentogenic strain while the polybasic cleavage site having sequence 112(R/K)RQ(R/K)RF117 is characteristic in mesogenic and Velogenic strains. 15, 16, 17 The monobasic cleavage site is the substrate only for trypsin and furin-like enzymes that are only present in the intestinal and respiratory tract, so the risk of systemic infection is minimized. On the contrary, the polybasic sites are cleaved by host proteases that are present in a wide range of host cells and tissues leading to a more lethal systemic infection.18, 19

This study was conducted to isolate the cause behind the prevalent infection and its molecular characterization for identification as well as phylogenetic analysis to find the relatedness of each isolate. On referring to the publications of other researchers, the clinical manifestations of this disease including circulatory and respiratory disturbance (watery eyes, rales, sneezing) nervous signs (wryneck), and hemorrhagic lesions in the intestine, trachea, and proventriculus gland turned out to be the characteristic signs of Newcastle disease.20

Out of the 80 total samples, 22 were found to be hemagglutinating. Furthermore, initial confirmation via Hemagglutination Inhibition Assay using Monoclonal antisera (GD Laboratories Holland-Lot no: 23129-110523) and final testing via PCR led to the outcome that 14 of the 22 hemagglutinating isolates were positive for NDV. Moreover, the sequencing of the PCR product and its phylogenetic analysis along with the reference strains as shown in Figure 2 further contributed to the efficient pathotyping of NDV. All of the isolates had the sequence 112(R/K)RQ(R/K)RF117 at the cleavage site of Fusion protein characterizing them to be the virulent NDV strains per OIE21 except for OP17(OR269159) and OP22(PP316616) that belong to vaccinal lentogenic LaSota strain having the fusion protein cleavage site sequence112 (G/E)(K/R)Q(G/E)RL117.16

The fusion protein-based analysis of the isolated NDV strains predicted that five out of fourteen isolates belong to Genotype II, one belongs to Genotype III and the rest of the eight belong to Genotype VII. Among Genotype II isolates OP13 (OQ622086) and OP22 (PP316616) showed 100%, 100%, 99.46%, 100%, and 98.09% similarity to NCBI accession numbers MH407220 and MZ041713 respectively. While remaining 3 isolates OP14 (OQ622087), OP15 (OQ789656), and OP17 (OR269159) showed 100%, 99.46%, and 100% identity to NCBI accession number MN599095. Whereas, Genotype III isolate OP21 (PP228199) showed 98.09% similarity to accession number MH392214.

Furthermore, among eight Genotype VII isolates, five of them including OP12 (OQ363107), OP16 (OR269160), OP18 (OR853727), OP19 (OR982193), and OP20 (PP196615) depicted 97.77%, 95.90%, 99.32%, 99.32%, and 100% similarity to NCBI accession numbers OK338515, MK903023, MN481193, OK338510, and OR514717. In contrast, the remaining three isolates OP23 (PP359476), OP24 (PP359477), and OP25 (PP388965) turned out to be 99.32%, 100%, and 91.33% identical to accession number OR982193.

Amongst the fourteen indigenous isolates from Punjab, Pakistan, two isolates OP12 and OP16 had a resemblance to Avian Paramyxovirus Serotype 1 strain abc2 whilst two other isolates OP14 and OP15 were similar to the strain Ae016. Similarly, OP17 and OP22 were categorized as LaSota strain, OP13 as AAvV1-NVMoh19/Iraq/2016, OP18 as chicken/Iran/CI3/2017, and OP21 as I2. However, the remaining five isolates OP19, OP20, OP23, OP24, and OP25 mimic the Newcastle Disease Virus strain Ck/IR/EMA128/2018.

Moreover, the phylogenetic analysis of these fourteen isolates can be referred to Figure 2 demonstrating that the severity of the pathogenesis of prevalent strains irrespective of the immunization of those flocks with vaccinal NDV strain can be attributed to the genetical difference among field isolates and vaccinal strains.22 Hence, severe local and systemic damage in the poultry infected with these isolates can be observed. The clinical records also predict the persistence of high viral load in the environment contributing to the point mutation in the Fusion protein gene of Newcastle disease virus which is ultimately the significant protein of NDV in terms of pathogenicity. These point mutations enable this virus to evade the immune response despite the presence of a protective level of F-protein antibodies against NDV as a result of the active immunization process.23

Likewise, the repetitive and unnecessary exposure of birds to the vaccinal strains also contributes to the emergence of diverse NDV pathotypes ultimately limiting the effectiveness of mass immunization as these pathotypes emerge to be widely resistant to the immune response elicited by the previous vaccinal strains.24 Therefore, the current study turns the tables by developing the understanding that constant isolation and pathotyping play a crucial part in developing effective vaccines and vaccine administration strategies to ensure the success of the immunization program. The use of these isolates as seeds in the future vaccine can eliminate the risk of vaccine failure in the future.25

The current study indicates that understanding the genetic nature and pathotyping of NDV has a pivotal role in developing efficacious vaccines and future vaccination strategies. Homologous isolates could be adopted as master seed viruses for vaccine production and the vaccination program can be revised according to need and environmental circumstances. Furthermore, partial F-gene sequence analysis has enabled us to study the cause of vaccine failure in 2022-23 outbreaks in different areas of Pakistan. Here, the author has contributed to the study of field isolates of NDV by pathotyping fourteen isolates OP12-OP25 and submitting them in NCBI GeneBank under the accession numbers OQ363107, OQ622086, OQ622087, OQ789656, OR269160, OR269159, OR853727, OR982193, PP196615, PP228199, PP316616, PP359476, PP359477, PP388965.

Conclusion

The results of the current study revealed that nucleotide mutation at various positions attributes amino acid substitution that enables wild prevailing strains to evade artificial active immunity. In such a scenario Chimeric and genotype match vaccines prepared from indigenous isolates may be useful in developing candidate vaccines to prevent virus shedding and infection. Further studies are suggested at the molecular level to determine the consensus amino acid sequence for virulent, mesogenic and avirulent of prevailing NDV strains.

Sources of Funding

Nil.

Conflict of Interest

None

References

1 

SS Ewies A Ali SM Tamam HM Madbouly Molecular characterization of Newcastle disease virus (genotype VII) from broiler chickens in EgyptBeni-Suef Univ J Basic Appl Sci2017632327

2 

MA Mayo A summary of taxonomic changes recently approved by ICTVArch Virol20021478165563

3 

S Krishnamurthy SK Samal Nucleotide sequences of the trailer, nucleocapsid protein gene and intergenic regions of Newcastle disease virus strain Beaudette C and completion of the entire genome sequenceJ Gen Virol199879Pt 10241924

4 

NM Monir LM Omar GF El-Bagoury SS Sharawi Isolation and Molecular Identification of Avian Paramyxovirus-1 from Broiler Outbreak in Qaliobia Governorate, EgyptBenha Vet Med J201834226577

5 

A Scheid PW Choppin Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virusVirology197457247090

6 

JCFM Dortmans G Koch PJM Rottier BPH Peeters Virulence of Newcastle disease virus: what is known so far?Vet Res2011421122

7 

EW Aldous JK Mynn J Banks DJ Alexander A molecular epidemiological study of avian paramyxovirus type 1 (Newcastle disease virus) isolates by phylogenetic analysis of a partial nucleotide sequence of the fusion protein geneAvian Pathol200332323956

8 

KM Dimitrov HL Ferreira MJ Pantin-Jackwood TL Taylor IV Goraichuk BM Crossley Pathogenicity and transmission of virulent Newcastle disease virus from the 2018-2019 California outbreak and related viruses in young and adult chickensVirology201953120318

9 

Y Huang HQ Wan HQ Liu YT Wu XF Liu Genomic sequence of an isolate of Newcastle disease virus isolated from an outbreak in geese: a novel six nucleotide insertion in the non-coding region of the nucleoprotein geneArch Virol20041497144557

10 

DJ Alexander Newcastle diseaseA laboratory manual for the isolation and identification of avian pathogensKendall/Hunt Publishing CompanyDubuque, IA198911420

11 

Z Huang S Krishnamurthy A Panda SK Samal Newcastle Disease Virus V Protein Is Associated with Viral Pathogenesis and Functions as an Alpha Interferon AntagonistJ Virol20037716867685

12 

GE Gallili D Ben-Nathan Newcastle disease vaccinesBiotechnol Adv199816234366

13 

M Habibian S Ghazi MM Moeini A Abdolmohammadi Effects of dietary selenium and vitamin E on immune response and biological blood parameters of broilers reared under thermoneutral or heat stress conditionsInt J Biometeorol201458574152

14 

PJ Miller EL Decanini CL Afonso Newcastle disease: Evolution of genotypes and the related diagnostic challengesInfect Genet Evol20101012635

15 

MS Collins JB Bashiruddin DJ Alexander Deduced amino acid sequences at the fusion protein cleavage site of Newcastle disease viruses showing variation in antigenicity and pathogenicityArch Virol19931283-436370

16 

OSD Leeuw G Koch L Hartog N Ravenshorst BP Peeters Virulence of Newcastle disease virus is determined by the cleavage site of the fusion protein and by both the stem region and globular head of the haemagglutinin-neuraminidase proteinJ Gen Virol200586Pt 6175969

17 

A Panda Z Huang S Elankumaran DD Rockemann SK Samal Role of fusion protein cleavage site in the virulence of Newcastle disease virusMicrob Pathog2004361110

18 

W Garten W Berk Y Nagai R Rott HD Klenk Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicityJ Gen Virol198050113547

19 

Y Nagai HD Klenk R Rott Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virusVirology1976722494508

20 

AAA Dewidar AA El-Sawah SAS Shany AHM Dahshan A Ali Genetic characterization of genotype VII.1.1 Newcastle Disease viruses from commercial and backyard broiler chickens in EgyptGer J Vet Res202114117

21 

Newcastle diseaseOIE Terrestrial ManualOIEParis2012

22 

HA Sultan S Talaat WK Elfeil K Selim MA Kutkat SA Amer Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layersPoult Sci2020993127586

23 

KM Dimitrov CL Afonso Q Yu PJ Miller Newcastle disease vaccines-A solved problem or a continuous challenge?Vet Microbiol201720612636

24 

P J Miller L M Kim H S Ip C L Afonso Evolutionary dynamics of Newcastle disease virus20093916472

25 

MB Bello K Yusoff A Ideris M Hair-Bejo BPH Peeters AR Omar Diagnostic and Vaccination Approaches for Newcastle Disease Virus in Poultry: The Current and Emerging PerspectivesBiomed Res Int2018187278459



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 29-04-2024

Accepted : 21-05-2024


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijmr.2024.015


Article Metrics






Article Access statistics

Viewed: 448

PDF Downloaded: 120



Medical Abbreviation List